Zurcher Kantonalbank (Zurich Cantonalbank) Legend Biotech Corp Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Legend Biotech Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 50,268 shares of LEGN stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,268

Previous 31,070 61.79%

Holding current value

$2.01 Million

Previous $1.38 Million 77.98%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$43.55 - $59.88 $836,072 - $1.15 Million	19,198 Added 61.79%	50,268 $2.45 Million
Q2 2024 Jul 29, 2024	BUY	$39.5 - $57.22 $251,457 - $364,262	6,366 Added 25.77%	31,070 $1.38 Million
Q1 2024 Apr 25, 2024	BUY	$55.06 - $69.99 $366,974 - $466,483	6,665 Added 36.95%	24,704 $1.39 Million
Q4 2023 Jan 30, 2024	BUY	$57.25 - $69.74 $291,059 - $354,558	5,084 Added 39.24%	18,039 $1.09 Million
Q3 2023 Oct 25, 2023	SELL	$63.16 - $76.5 $262,492 - $317,934	-4,156 Reduced 24.29%	12,955 $870,000
Q2 2023 Aug 07, 2023	SELL	$46.28 - $75.01 $1,203 - $1,950	-26 Reduced 0.15%	17,111 $1.18 Million
Q1 2023 May 08, 2023	BUY	$43.42 - $57.37 $220,573 - $291,439	5,080 Added 42.13%	17,137 $826,000
Q4 2022 Feb 01, 2023	SELL	$38.8 - $55.46 $388 - $554	-10 Reduced 0.08%	12,057 $601,000
Q2 2022 Aug 09, 2022	SELL	$33.54 - $55.0 $344,153 - $564,355	-10,261 Reduced 45.96%	12,067 $664,000
Q1 2022 Apr 21, 2022	BUY	$31.02 - $48.18 $215,806 - $335,188	6,957 Added 45.26%	22,328 $811,000
Q4 2021 Feb 01, 2022	BUY	$41.14 - $56.98 $437,770 - $606,324	10,641 Added 224.97%	15,371 $716,000
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $167,016 - $239,148	4,730 New	4,730 $239,000

Others Institutions Holding LEGN

# of Institutions

205

Shares Held

74.5M

Call Options Held

371K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Legend Biotech Corp Transaction History